4534 — Mochida Pharmaceutical Co Balance Sheet
0.000.00%
- ¥105bn
- ¥54bn
- ¥105bn
- 94
- 69
- 72
- 93
Annual balance sheet for Mochida Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | — | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 63,486 | 61,914 | 60,509 | 46,789 | 51,150 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 29,189 | 31,676 | 27,806 | 34,838 | 31,617 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 118,793 | 121,448 | 117,379 | 116,662 | 119,669 |
Net Property, Plant And Equipment | 13,299 | 14,528 | 15,049 | 15,874 | 15,940 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 161,791 | 163,139 | 158,831 | 158,800 | 160,121 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 28,710 | 29,856 | 27,258 | 26,073 | 24,902 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 34,817 | 34,493 | 32,056 | 30,833 | 29,427 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 126,974 | 128,646 | 126,775 | 127,967 | 130,694 |
Total Liabilities & Shareholders' Equity | 161,791 | 163,139 | 158,831 | 158,800 | 160,121 |
Total Common Shares Outstanding |